Back to Search
EUN GRACE KIM, DO
DO
Internal Medicine Physician
NPI: 1821739624IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
V9042(TX)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2022
Research & Publications (20)
Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes.
PMID 19052171·Mol Pharmacol·2009
4-observational
Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.
PMID 19318668·Chest·2009
8-other
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.
PMID 19027483·Lancet·2008
3-trial
Ascl1 (Mash1) lineage cells contribute to discrete cell populations in CNS architecture.
PMID 18585058·Mol Cell Neurosci·2008
4-observational
Estimating P-coverage of biosynthetic pathways in DNA libraries and screening by genetic selection: biotin biosynthesis in the marine microorganism Chromohalobacter.
PMID 18493659·Mol Biosyst·2008
8-other
Nephrin binds to the COOH terminus of a large-conductance Ca2+-activated K+ channel isoform and regulates its expression on the cell surface.
PMID 18480178·Am J Physiol Renal Physiol·2008
7-preclinical
Alternatively spliced C-terminal domains regulate the surface expression of large conductance calcium-activated potassium channels.
PMID 17478049·Neuroscience·2007
7-preclinical
Interactions with filamin A stimulate surface expression of large-conductance Ca2+-activated K+ channels in the absence of direct actin binding.
PMID 17586600·Mol Pharmacol·2007
8-other
Beta1-subunits increase surface expression of a large-conductance Ca2+-activated K+ channel isoform.
PMID 17329633·J Neurophysiol·2007
8-other
An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesis.
PMID 15558016·Oncogene·2005
7-preclinical
Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma.
PMID 16028213·Cancer·2005
3-trial
Cetuximab as a single agent or in combination with chemotherapy in lung cancer.
PMID 15638964·Clin Lung Cancer·2004
6-review
Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
PMID 15140551·Lung Cancer·2004
3-trial
Treatment of metastatic head and neck cancer: chemotherapy and novel agents.
PMID 12619547·Cancer Treat Res·2003
6-review
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer.
PMID 11714540·Lung Cancer·2001
3-trial
Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer.
PMID 19680729·Ann Surg Oncol·2010
4-observational
The common exon 3 polymorphism of the growth hormone receptor gene and the effect of growth hormone therapy on growth in Korean patients with Turner syndrome.
PMID 19681916·Clin Endocrinol (Oxf)·2010
8-other
Erythrobacter gangjinensis sp. nov., a marine bacterium isolated from seawater.
PMID 19671726·Int J Syst Evol Microbiol·2010
8-other
Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
PMID 19664879·Cancer Lett·2010
7-preclinical
Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area.
PMID 19672964·Head Neck·2010
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2400 N INTERSTATE 35 E RD
WAXAHACHIE, TX 75165 - Phone
- (972) 923-7144
Quick Facts
- NPI
- 1821739624
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile